Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
Phase 2 Completed
40 enrolled
METIMMOX
Phase 2 Completed
80 enrolled 13 charts
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
Phase 1 Completed
174 enrolled
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Phase 1/2 Completed
64 enrolled 20 charts
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
38 enrolled
CLIMB
Phase 2 Completed
20 enrolled
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
Phase 2 Completed
18 enrolled 16 charts
OBELICS
Phase 3 Completed
230 enrolled 12 charts
Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
Phase 2 Completed
8 enrolled 11 charts
ELANFIT
Phase 2 Completed
85 enrolled
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
Phase 3 Completed
499 enrolled 22 charts
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
Phase 2 Completed
38 enrolled 14 charts
POSIBA
Phase 2 Completed
221 enrolled 17 charts
OPALO
Phase 2 Completed
20 enrolled
MATEO
Phase 2 Completed
242 enrolled
Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Completed
FOLFOX-D
Phase 2 Completed
44 enrolled 18 charts
BEV-ONCO2012
Phase 2 Completed
60 enrolled
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Phase 1 Completed
32 enrolled
LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer
Phase 1 Completed
39 enrolled
Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Phase 2 Completed
100 enrolled 13 charts
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
Phase 1 Completed
167 enrolled
Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
Phase 1 Completed
142 enrolled 28 charts
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Phase 1/2 Completed
50 enrolled
AXEPT
Phase 3 Completed
650 enrolled
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Completed
40 enrolled
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Phase 2 Completed
266 enrolled 17 charts
Molecularly Tailored Therapy for Pancreas Cancer
Phase 2 Completed
19 enrolled
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
Phase 1 Completed
17 enrolled
Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 2 Completed
49 enrolled 5 charts
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 2 Completed
73 enrolled
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
Phase 1 Completed
24 enrolled
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 3 Completed
135 enrolled
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 2 Completed
44 enrolled
AFFIRM
Phase 2 Completed
268 enrolled 16 charts
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Phase 1 Completed
180 enrolled
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
Phase 3 Completed
879 enrolled
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
Phase 2 Completed
48 enrolled 8 charts
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Phase 2 Completed
26 enrolled 24 charts
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
Phase 1 Completed
14 enrolled
Phase I Trial of Combination of FOLFIRI and SOM 230
Phase 1 Completed
16 enrolled
Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic
Phase 2 Completed
29 enrolled
Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
Phase 3 Completed
570 enrolled
COMETS
Phase 3 Completed
110 enrolled
Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix
Completed
30 enrolled
Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects
Phase 2 Completed
198 enrolled 18 charts
ADVANTAGE
Phase 1/2 Completed
184 enrolled 20 charts
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
Phase 1/2 Completed
172 enrolled 12 charts
Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
Phase 2 Completed
Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)
Phase 1/2 Completed